Finance Minister Nirmala Sitharaman announced a network of over 1,000 accredited clinical trial sites to expand research ...

Disapproving of the use of Stem Cell Treatment (SCT) for Autism Spectrum Disorder (ASD) as regular clinical treatment, the Supreme Court recently clarified that therapeutic use of ...

Finance Minister Nirmala Sitharaman announces Biopharma Shakti, a ₹10,000 crore plan to boost biologics, biosimilars, ...

New Delhi: Finance Minister Nirmala Sitharaman on Sunday said the government will create a network of over 1,000 accredited ...

Finance Minister Nirmala Sitharaman on Sunday (1 February) presented the Union budget for the financial year 2026-27. This is ...

Ankle fractures are among the most common fractures in adults. Some ankle fractures are "stable," so the patient can carry on ...

Cancellation of a trial of a cancer drug based on research by accused scientific fraudster Mark Smyth has confirmed fears of ...

Doctors on Saturday welcomed the Supreme Courts order against the use of stem cell therapy to treat autism -- a ...

The BioPharma Shakti initiative aims to strengthen research, clinical trials, and regulatory capacity amid India’s rising non ...

As non-communicable diseases overtake infections, the Shakti scheme aims to build a globally competitive ecosystem for ...

The race to slow, halt, or even reverse aging has moved from science fiction into the regulatory record. A Harvard-linked startup, Life Biosciences, has secured clearance from the U.S. Food and Drug ...

The heated debate unfolded on X yesterday.